1. Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA, and the Transfusion Safety Study Group. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. Transfusion 1991 ;31:4–11.
2. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of HIV transmission by screened blood in the United States. N Engl J Med 1995;333:1721–25.
3. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685–90.
4. Busch MP, Korelitz JJ, Kleinman SH, Lee SR, AuBuchon JP, Schreiber GB. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C vims infection. The Retrovirus Epidemiology Donor Study. Transfusion 1995;35:903–10.
5. Nelson KE, Ahmed F, Stambolis V, Ness PM, Yawn D, McAlister H. Incident hepatitis C virus (HCV) and hepatitis virus (HBV) infections in transfused cardiac surgery patients: Infection rates during different methods of donor screening. In Infectious disease testing for blood transfusions. Consensus development conference. Bethesda: National Institutes of Health, 1995.